Literature DB >> 32240310

The utility of magnetic resonance imaging lesion combinations in the sacroiliac joints for diagnosing patients with axial spondyloarthritis. A prospective study of 204 participants including post-partum women, patients with disc herniation, cleaning staff, runners and healthy persons.

Sengül Seven1,2, Mikkel Østergaard1,2, Lone Morsel-Carlsen3, Inge Juul Sørensen1, Birthe Bonde4, Gorm Thamsborg1, Jens Jørgen Lykkegaard1, Oliver Hendricks5, Niklas Rye Jørgensen6,7, Susanne Juhl Pedersen1,2.   

Abstract

OBJECTIVES: To investigate the diagnostic utility of different combinations of SI joint MRI lesions for differentiating patients with axial SpA (axSpA) from other conditions with and without buttock/pelvic pain.
METHODS: A prospective cross-sectional study included patients with axSpA (n = 41), patients with lumbar disc herniation (n = 25), women with (n = 46) and without (n = 14) post-partum (birth within 4-16 months) buttock/pelvic pain and cleaning assistants (n = 26), long-distance runners (n = 23) and healthy men (n = 29) without pain. Two independent readers assessed SI joint MRI lesions according to the Spondyloarthritis Research Consortium of Canada MRI definitions and pre-defined MRI lesion combinations with bone marrow oedema (BME) and fat lesions (FAT), respectively. Statistical analyses included the proportion of participants with scores above certain thresholds, sensitivity, specificity, positive and negative predictive values and likelihood ratios.
RESULTS: BME adjacent to the joint space (BME@joint space) was most frequent in axSpA (63.4%), followed by women with post-partum pain (43.5%), but was present in nearly all groups. BME adjacent to fat lesions (BME@FAT) and BME adjacent to erosions (BME@erosion) were only present in axSpA patients and in women with post-partum pain, but scores ≥3 and ≥4, respectively, were only seen in axSpA patients. FAT@erosion was exclusively recorded in axSpA patients. FAT@joint space and FAT@sclerosis were present in most groups, but with higher scores in the axSpA group.
CONCLUSION: BME@joint space and FAT@joint space were frequent in axSpA but also in other conditions, reducing the diagnostic utility. FAT@erosion, and BME@FAT, BME@erosion and FAT@sclerosis above certain thresholds, were exclusively seen in axSpA patients and may thus have diagnostic utility in the differentiation of axSpA from other conditions.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  axial spondyloarthritis; inflammation; magnetic resonance imaging; post-partum women; sacroiliac joints

Mesh:

Year:  2020        PMID: 32240310     DOI: 10.1093/rheumatology/keaa096

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  4 in total

1.  Sacroiliac Bone Marrow Edema: Innocent Until Proven Guilty?

Authors:  Michael M Ward; Lawrence Yao
Journal:  Arthritis Rheumatol       Date:  2022-08-09       Impact factor: 15.483

Review 2.  Imaging in Axial Spondyloarthritis: What is Relevant for Diagnosis in Daily Practice?

Authors:  Ulrich Weber; Anne Grethe Jurik; Robert G W Lambert; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

3.  Frequency and anatomic distribution of magnetic resonance imaging lesions in the sacroiliac joints of spondyloarthritis and non-spondyloarthritis patients.

Authors:  Sophie Hecquet; Jean-Philippe Lustig; Frank Verhoeven; Mickaël Chouk; Sébastien Aubry; Daniel Wendling; Clément Prati
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-09-05       Impact factor: 3.625

4.  MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis.

Authors:  Chun-Chi Lu; Guo-Shu Huang; Tony Szu-Hsien Lee; En Chao; Hsiang-Cheng Chen; Yong-Si Guo; Shi-Jye Chu; Feng-Cheng Liu; San-Yuan Kao; Tsung-Yun Hou; Chen-Hung Chen; Deh-Ming Chang; Sin-Yi Lyu
Journal:  J Transl Med       Date:  2021-07-09       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.